Montpellier, France, March 14, 2016 – MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, today announced three new sales of its ROSA® Brain robotic surgery system in the United States and China.
The Yale Comprehensive Epilepsy Center in New Haven, Connecticut, purchased one system. The facility provides promising treatment options for many adult and pediatric patients. Yale is also internationally recognized for its clinical excellence and innovative research.
The ROSA® Brain system at the Yale Comprehensive Epilepsy Center will be used for minimally invasive procedures such as stereoelectroencephalography (SEEG), deep brain stimulation, and biopsies. The program will be led by Dennis Spencer, MD, Surgical Director and Harvey and Kate Cushing Professor of Neurosurgery; and Jason Gerrard, MD, PhD, Assistant Professor of Neurosurgery and of Neuroscience and Section Chief, Stereotactic and Functional Neurosurgery.
The other two sales of ROSA® Brain were made in China, a fast-growing market representing a strong opportunity for Medtech. With these two new sales, Medtech now has nine ROSA® robots in the Chinese territory.
“We are pleased to continue to expand our ROSA® technology in these large neurosurgical markets,” said Bertin Nahum, CEO and Founder of Medtech. “The three new sales in China and the United States testify to the positive momentum of our commercial activity.”